ClinicalTrials.gov
ClinicalTrials.gov Menu

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00851929
Recruitment Status : Completed
First Posted : February 26, 2009
Last Update Posted : August 2, 2018
Sponsor:
Collaborator:
Gilead Sciences
Information provided by:
Medical University of South Carolina

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2011
  Actual Study Completion Date : November 2011